Evaluating heart activity using advanced ECG technology
Official title: Evaluation of Electrocardiographic Measurements by High Density Electrode ECG
Run by University Hospital, Bordeaux · NCT04921501 · Data updated 2026-11-12
This study is testing a new heart monitoring technology to see if it can better detect heart problems in patients with serious arrhythmias compared to the standard method.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 14 Years and up |
| Sex | All |
| Enrollment | 1800 (estimated) |
| Sponsor | University Hospital, Bordeaux Academic / other |
| Locations | 11 sites (Clermont-Ferrand and 10 other locations) |
| Status | Recruiting |
| Started | April 6, 2021 |
| Main results expected | April 2027 |
| Study ends | April 2027 |
| Registry record updated | December 24, 2024 |
| Trial ID | NCT04921501 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients with documented severe ventricular arrhythmias or those at high risk for sudden cardiac events, such as those with low ejection fraction or a history of ventricular tachycardia.
✕Probably not a fit
Patients under 14 years old or those who are pregnant or nursing may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of high-density electrocardiography (HD ECG) with 128 body surface leads compared to conventional 12-lead ECG in detecting cardiac electrical activity. The aim is to improve sensitivity in measuring global or regional cardiac activity, particularly in patients with severe ventricular arrhythmias. By capturing more comprehensive data, the study seeks to provide additional clinical insights that could enhance patient management and treatment outcomes.
Why it matters
Potential benefit: If successful, this approach could lead to better detection and management of ventricular arrhythmias, potentially improving patient outcomes.
How similar studies have gone: While the use of high-density ECG is a novel approach, similar studies have shown promise in enhancing cardiac monitoring and diagnostics.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient managed at the Bordeaux University Hospital for assessment of documented severe ventricular arrhythmia (VF, sudden resuscitated death) or suspected (syncope, family history of sudden death, ECG or Holter abnormality) or impaired ventricular conduction, OR * Patients managed for prophylactic ventricular defibrillator implantation, according to international recommendations: Heart disease with ejection fraction \< 35%, heart disease with sustained ventricular tachycardia, cardiomyopathies with high rhythmic risk, * Women of childbearing age with effective contraception. Exclusion Criteria: * patients under 14 years old, * pregnant or nursing woman.
Where it's running
-
Bordeaux University Hospital
Pessac, France Recruiting -
CHU Clermont-Ferrand
Clermont-Ferrand, France Not yet recruiting -
Hôpital Privé Jacques Cartier
Massy, France Not yet recruiting -
Hôpital Pitié-Salpêtrière
Paris, France Not yet recruiting -
Hôpital Bichat
Paris, France Not yet recruiting -
Hôpital européen Georges Pompidou
Paris, France Not yet recruiting
Show 5 more locations
-
CHR Pontchaillou
Rennes, France Not yet recruiting -
CHU de Saint-Etienne
Saint-Etienne, France Not yet recruiting -
CHU de Toulouse
Toulouse, France Not yet recruiting -
CHU de Nancy
Vandœuvre-lès-Nancy, France Not yet recruiting -
Centre Hospitalier Princesse Grace
Monaco, Monaco Not yet recruiting
Study contacts
- Principal investigator: Michel HAÏSSAGUERRE, MD-PhD — University Hospital, Bordeaux
- Study coordinator: Michel HAÏSSAGUERRE, MD-PhD
- Email: michel.haissaguerre@chu-bordeaux.fr
- Phone: (0)5 57 65 64 71
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pulsed Field Ablation for Ventricular Arrhythmias
This study tests pulsed field ablation to treat ventricular arrhythmias in adults who are already planned for catheter ablation.
-
Do medicines that lengthen the heart's QT interval cause serious heart problems in hospitalized adults?
This project will test whether commonly used hospital medicines that can prolong the heart's QT interval lead to serious cardiac events in adults admitted to Ontario hospitals.
-
Evaluating dexmedetomidine for treating electrical storm in patients
This study is testing if a sedative called dexmedetomidine can help adults with electrical storm, which causes dangerous heart rhythms, by reducing these episodes and improving their recovery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.